CLINICAL_TRIALS
trial_result
· 2022-09-29
Clinical Trial Update: Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events [Phase 4]
Summary
Phase 4 clinical trial update on loiasis examining cross-reactive antigenemia and treatment-related adverse events.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Washington University School of Medicine | Conditions: Loiasis | Phase 4 | Status: COMPLETED | Results posted: 2022-09-29